Welcome to LookChem.com Sign In|Join Free
  • or
2-Oxazolidinone, 3-[4-(3,4-dimethoxyphenyl)-3-(tributylstannyl)-3-butenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

864755-91-9

Post Buying Request

864755-91-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

864755-91-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 864755-91-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,4,7,5 and 5 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 864755-91:
(8*8)+(7*6)+(6*4)+(5*7)+(4*5)+(3*5)+(2*9)+(1*1)=219
219 % 10 = 9
So 864755-91-9 is a valid CAS Registry Number.

864755-91-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-[3-(tributylstannanyl)-4-(3,4-dimethoxyphenyl)-but-3-enyl]-1,3-oxazolidine-2-one

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:864755-91-9 SDS

864755-91-9Downstream Products

864755-91-9Relevant academic research and scientific papers

Alkenyldiarylmethanes, Fused Analogs And Syntheses Thereof

-

Page/Page column 22; 8, (2009/01/20)

Non-nucleoside inhibitors of HIV-1 reverse transcriptase are described. Such inhibitors may be used as part of a combination therapy to treat HIV infection. Compounds described herein exhibit antiviral potency. In addition, compounds described herein exhibit metabolic stability. Also described herein are processes for preparing Non-nucleoside inhibitors of HIV-1 reverse transcriptase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 864755-91-9